Alpha4-integrin antagonism — an effective approach for the treatment of inflammatory diseases?
Authors:
- Richard J. DavenportRDRichard J. Davenport
- James R. MundayJMJames R. Munday
- 1 July 2007
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 12 (13-14) , 569-576
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Synthesis and Biological Evaluation of Novel Pyridazinone-Based α4Integrin Receptor AntagonistsJournal of Medicinal Chemistry, 2006
- Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthmaJournal of Allergy and Clinical Immunology, 2005
- Potent Cyclic Monomeric and Dimeric Peptide Inhibitors of VLA-4 (?4?1 Integrin)-Mediated Cell Adhesion Based on the Ile-Leu-Asp-Val TetrapeptideJournal of Peptide Science, 2000
- The design and synthesis of potent cyclic peptide VCAM–VLA-4 antagonists incorporating an achiral Asp-Pro mimeticBioorganic & Medicinal Chemistry Letters, 2000
- Correlation of Biliary Excretion in Sandwich-Cultured Rat Hepatocytes and In Vivo in RatsDrug Metabolism and Disposition, 1999
- Drug metabolism in hepatocyte sandwich cultures of rats and humansBiochemical Pharmacology, 1997
- Application of primary hepatocyte sandwich cultures for predictive studies of drug metabolism and precarcinogen activation1997
- A novel cyclic pentapeptide inhibits alpha 4 beta 1 and alpha 5 beta 1 integrin-mediated cell adhesion.Journal of Biological Chemistry, 1993
- α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1Cell, 1993
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992